Drug Profile
Sperabillin A
Alternative Names: TAN 749Latest Information Update: 13 Oct 2000
Price :
$50
*
At a glance
- Originator Takeda
- Class Antibacterials; Antineoplastics
- Mechanism of Action Cell wall inhibitors; DNA synthesis inhibitors; Protein synthesis inhibitors; RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 13 Oct 2000 Discontinued-Unspecified phase in Bacterial infections in Japan (Unknown route)
- 12 Jun 2000 Profile reviewed but no significant changes made